This article is for general education. The Bimini NanoJet is a wellness device and is not intended to diagnose, treat, cure or prevent concussion, long COVID or any other condition. Talk to your physician before adding any wellness routine.
Millions of people feel "fine on paper" but broken in real life. Normal labs, normal imaging, normal resting oxygen — and yet walking up a flight of stairs feels like climbing a mountain. For the long COVID and chronic fatigue syndrome (ME/CFS) communities, this maddening gap between test results and lived experience is daily reality. The emerging consensus: the problem isn't the lungs or the heart, it's how oxygen is being used at the cellular level.
This article unpacks the mitochondrial-dysfunction hypothesis of long COVID and chronic fatigue, why researchers are interested in tissue-level oxygen delivery, and where the evidence currently stands.
The Bioenergetic Signature of Long COVID
Research published in Nature Communications and Cell from 2022-2024 converges on a central finding: long COVID patients show measurable abnormalities in mitochondrial function, capillary density, and tissue-level oxygen utilization. Key findings:
- Reduced muscle oxygen extraction: Exercise studies show long COVID patients extract 15-30% less oxygen from blood during activity, despite normal delivery.
- Mitochondrial swelling: Muscle biopsies show ultrastructural mitochondrial damage consistent with chronic oxidative stress.
- Microclot persistence: Amyloid fibrin microclots obstruct capillaries, impairing local oxygen delivery even when arterial saturation is normal.
- Endothelial dysfunction: Blood vessel walls fail to dilate appropriately during exertion, reducing tissue perfusion.
Key insight: Long COVID's fatigue isn't lung failure; it's cellular oxygen utilization failure. Standard pulse-ox readings miss it entirely.
Why Post-Exertional Malaise Is So Disabling
Post-exertional malaise (PEM) — the disproportionate crash 24-72 hours after even modest activity — is the hallmark symptom of both long COVID and ME/CFS. Unlike normal fatigue, PEM doesn't resolve with rest alone. Research suggests PEM reflects:
- A rapid switch to anaerobic metabolism at low workloads (lactate accumulation).
- Depletion of already-compromised ATP reserves.
- Inflammatory cytokine release that takes days to clear.
- Disrupted autonomic recovery (heart rate variability remains suppressed for days).
This is why "just push through it" protocols fail — and often worsen — long COVID. Graded exercise programs that ignore PEM can simply deepen the cellular energy deficit.
Why Researchers Are Interested in Tissue-Level Oxygen
If the core problem is how cells access and use oxygen, it is natural to ask whether delivering oxygen differently could matter. Three observations drive research interest in transdermal oxygen delivery — none of which amounts to clinical proof:
1. Delivery Independent of Circulatory Bottlenecks
Because oxygen nanobubbles diffuse through skin rather than via hemoglobin transport, they are not fully dependent on the microcirculation that long COVID research implicates. Whether this translates into meaningful benefit in post-viral conditions has not been established.
2. Parasympathetic Activation
Warm-water immersion shifts autonomic balance toward parasympathetic dominance. This is of interest because autonomic dysfunction affects an estimated 60-70% of long COVID patients and drives POTS, exercise intolerance, and sleep disruption.
3. No Exertion Required
Unlike exercise-based approaches, warm-water immersion requires no physical effort. Researchers studying post-viral conditions pay close attention to interventions that avoid exertion, because exertion is the primary trigger of PEM.
To be clear: direct clinical trials of transdermal oxygen delivery in long COVID or ME/CFS do not yet exist. The observations above explain research interest, not proven benefit.
What Oxygen Devices Can't Do
Honesty matters here. No wellness device is a cure for long COVID or ME/CFS. A warm oxygen bath does not clear microclots, reverse autoimmunity, or address viral persistence if present.
Physician-directed long COVID care typically combines:
- Strict pacing and PEM avoidance
- Medical workup for POTS, mast cell activation, and autonomic dysfunction
- Appropriate pharmacologic intervention where indicated
- Graded cardiovascular reconditioning when and if tolerated
- Sleep, nutrition, and inflammation management
The Emerging Research Landscape
Formal clinical trials of various oxygen-based interventions in long COVID are underway, including hyperbaric oxygen therapy (HBOT) and transdermal delivery systems. Early HBOT data in long COVID has been promising but access is limited by cost ($300-500/session) and facility availability.
At-home wellness devices change the access question, but convenience is not evidence: trial data specific to transdermal delivery in post-viral conditions is still ahead of us.
Tracking Your Recovery Objectively
Long COVID recovery is often invisible day-to-day but visible week-over-week if you measure the right things:
Heart Rate Variability (HRV)
A wearable that tracks morning HRV (Whoop, Oura, Garmin) is one of the most sensitive markers of autonomic recovery. Rising 7-day rolling HRV averages are a reliable signal that oxygenation, sleep, and autonomic balance are improving together. Expect slow gains — 5-10% over a month is meaningful.
Resting Heart Rate
Morning resting HR typically drops as mitochondrial efficiency returns. A 3-5 bpm reduction over 4-8 weeks is a modest but real recovery signal.
Functional Capacity (The "Grocery Store Test")
Informal but powerful: track how you feel 48 hours after ordinary activities. Can you carry groceries up stairs without symptom flare? Walk around a supermarket without needing to sit? These markers are more meaningful than formal exercise tolerance tests in the early recovery phase.
Cognitive Markers
Brain fog improvements often lag physical recovery by 2-3 weeks. Apps like Dual N-Back or simple reaction time tests can track week-over-week changes.
What Recovery Often Looks Like
The honest reality: long COVID recovery is rarely linear. Most patients describe a "two steps forward, one step back" trajectory for months. Stability — fewer severe crashes, a steadier baseline — tends to come before capacity, and that stability is the platform from which graded rehabilitation finally becomes possible.
Historical Context: The Post-Viral Fatigue Legacy
Long COVID isn't new in its mechanisms — just in its scale. Post-viral fatigue syndromes have followed every major viral epidemic in recorded medical history: post-SARS (2003), post-H1N1 (2009), post-Epstein-Barr (decades of ME/CFS cases), and post-Lyme sequelae all share overlapping signatures of mitochondrial dysfunction, autonomic instability, and tissue-level oxygen utilization problems.
What has changed with long COVID is the research investment. Funding for post-viral fatigue research increased roughly 50-fold between 2019 and 2024. That surge has produced the first generation of mechanism-specific tools: microclot imaging, cellular bioenergetic assays, and clinical trials of interventions that would have been considered fringe a decade ago.
What the ME/CFS Community Taught Us
The ME/CFS community had been advocating for decades that post-exertional malaise was real, measurable, and bioenergetic. Long COVID research vindicated that framework. The legacy is a robust set of validated pacing protocols, symptom-tracking tools, and patient-led research methods that benefit every post-viral population.
A Shared Bioenergetic Problem
Patients with chronic Lyme, post-SARS fatigue, ME/CFS, and long COVID share overlapping signatures of mitochondrial dysfunction and impaired oxygen utilization — which is why researchers treat tissue-level oxygen delivery as a question worth studying across post-viral populations, not just in long COVID.
The Recovery Mindset Shift
One of the most destructive ideas in post-viral recovery is "push through it." Decades of data show the opposite is true: aggressive pacing — staying below the symptom threshold to avoid PEM — is the single most important recovery behavior.
If you're caring for a loved one with long COVID, the most impactful thing you can do is protect their pacing.
The Bottom Line
Long COVID and chronic fatigue syndrome are, at their core, bioenergetic disorders — stories of cells that cannot use oxygen efficiently. That is why oxygen delivery has become an active research question, from clinical HBOT trials to newer delivery approaches. The evidence is early, and no consumer wellness device — the Bimini NanoJet included — is intended to treat long COVID or ME/CFS.
Curious about the technology itself? Learn how the NanoJet works.
Bimini systems are wellness devices, not medical devices, and are not intended to diagnose, treat, cure, or prevent any disease. If you have a medical condition or concerning symptoms, seek qualified medical guidance.
The Science of Transdermal Oxygen Therapy
Peer-reviewed research, clinical studies, and the mechanism behind nanobubble oxygen delivery.
Frequently Asked Questions
Can oxygen therapy cure long COVID?
How is NanoJet different from hyperbaric oxygen therapy (HBOT) for long COVID?
Learn About the Technology
The Bimini NanoJet is a wellness device, not a treatment for long COVID or chronic fatigue. If you are curious how oxygen nanobubble baths work, start here.
